BibTex format
@article{Nakajima:2022:10.1007/s00464-021-08650-4,
author = {Nakajima, K and Mintz, Y and Nickel, F and Arezzo, A and EAES, Technology Committee},
doi = {10.1007/s00464-021-08650-4},
journal = {Surg Endosc},
pages = {3340--3346},
title = {The EAES intellectual property awareness survey.},
url = {http://dx.doi.org/10.1007/s00464-021-08650-4},
volume = {36},
year = {2022}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - INTRODUCTION: The protection of intellectual property (IP) is one of the fundamental elements in the process of medical device development. The significance of IP, however, is not well understood among clinicians and researchers. The purpose of this study was to evaluate the current status of IP awareness and IP-related behaviors among EAES members. METHODS: A web-based survey was conducted via questionnaires sent to EAES members. Data collected included participant demographics, level of understanding the need, new ideas and solutions, basic IP knowledge, e.g., employees' inventions and public disclosure, behaviors before and after idea disclosures. RESULTS: One hundred and seventy-nine completed forms were obtained through an email campaign conducted twice in 2019 (response rate = 4.8%). There was a dominancy in male, formally-trained gastrointestinal surgeons, working at teaching hospitals in European countries. Of the respondents, 71% demonstrated a high level of understanding the needs (frustration with current medical devices), with 66% developing specific solutions by themselves. Active discussion with others was done by 53%. Twenty-one percent of respondents presented their ideas at medical congresses, and 12% published in scientific journals. Only 20% took specific precautions or appropriate actions to protect their IPs before these disclosures. CONCLUSIONS: The current level of awareness of IP and IP-related issues is relatively low among EAES members. A structured IP training program to gain basic IP knowledge and skill should be considered a necessity for clinicians. These skills would serve to prevent the loss of legitimate IP rights and avoid failure in the clinical implementation of innovative devices for the benefit of patients.
AU - Nakajima,K
AU - Mintz,Y
AU - Nickel,F
AU - Arezzo,A
AU - EAES,Technology Committee
DO - 10.1007/s00464-021-08650-4
EP - 3346
PY - 2022///
SP - 3340
TI - The EAES intellectual property awareness survey.
T2 - Surg Endosc
UR - http://dx.doi.org/10.1007/s00464-021-08650-4
UR - https://www.ncbi.nlm.nih.gov/pubmed/34363113
VL - 36
ER -